SK283391B6 - Azolové zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Azolové zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK283391B6
SK283391B6 SK1161-98A SK116198A SK283391B6 SK 283391 B6 SK283391 B6 SK 283391B6 SK 116198 A SK116198 A SK 116198A SK 283391 B6 SK283391 B6 SK 283391B6
Authority
SK
Slovakia
Prior art keywords
compounds
formula
methyl
hydrogen
fluorine
Prior art date
Application number
SK1161-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK116198A3 (en
Inventor
Mauro Napoletano
Cristina Fraire
Enrico Albini
Giovanna Schioppacassi
Original Assignee
Zambon Group S. P. A.
Isagro S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group S. P. A., Isagro S.P.A. filed Critical Zambon Group S. P. A.
Publication of SK116198A3 publication Critical patent/SK116198A3/sk
Publication of SK283391B6 publication Critical patent/SK283391B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Devices For Medical Bathing And Washing (AREA)
SK1161-98A 1996-02-28 1997-02-25 Azolové zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie SK283391B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000371A IT1283038B1 (it) 1996-02-28 1996-02-28 Composti azolici ad attivita' antimicotica per uso umano e veterinario
PCT/EP1997/000886 WO1997031903A1 (en) 1996-02-28 1997-02-25 Azole compounds endowed with antimycotic activity for human and veterinary use

Publications (2)

Publication Number Publication Date
SK116198A3 SK116198A3 (en) 1999-02-11
SK283391B6 true SK283391B6 (sk) 2003-07-01

Family

ID=11373418

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1161-98A SK283391B6 (sk) 1996-02-28 1997-02-25 Azolové zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (32)

Country Link
US (2) US5869512A (zh)
EP (1) EP0877739B1 (zh)
JP (1) JP2000505466A (zh)
KR (1) KR19990087363A (zh)
CN (1) CN1082050C (zh)
AP (1) AP9801328A0 (zh)
AT (1) ATE219066T1 (zh)
AU (1) AU713049B2 (zh)
BG (1) BG102711A (zh)
BR (1) BR9707773A (zh)
CA (1) CA2247390A1 (zh)
CZ (1) CZ291790B6 (zh)
DE (1) DE69713276T2 (zh)
DK (1) DK0877739T3 (zh)
EA (1) EA003189B1 (zh)
EE (1) EE03684B1 (zh)
ES (1) ES2176689T3 (zh)
GE (1) GEP20002091B (zh)
HU (1) HUP9900569A3 (zh)
IL (1) IL125701A (zh)
IT (1) IT1283038B1 (zh)
NO (1) NO983953L (zh)
NZ (1) NZ331919A (zh)
OA (1) OA10847A (zh)
PL (1) PL328582A1 (zh)
PT (1) PT877739E (zh)
SI (1) SI0877739T1 (zh)
SK (1) SK283391B6 (zh)
TR (1) TR199801688T2 (zh)
UA (1) UA55405C2 (zh)
WO (1) WO1997031903A1 (zh)
ZA (1) ZA971665B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296925B1 (it) 1997-12-05 1999-08-03 Zambon Spa Procedimento per la preparazione di composti ad attivita' antimicotica
US6297115B1 (en) * 1998-11-06 2001-10-02 Advanced Micro Devices, Inc. Cmos processs with low thermal budget
AU2003211498A1 (en) 2002-02-15 2003-09-04 Mitsui Chemicals, Inc. Optically active azole derivative and process for producing the same
GB0222964D0 (en) 2002-10-03 2002-11-13 Unilever Plc Polymeric film for water soluble package

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187399B (en) * 1980-12-24 1985-12-28 Sumitomo Chemical Co Process for preparing imidazolyl-propanol derivatives
EP0061835B1 (en) * 1981-03-18 1989-02-01 Imperial Chemical Industries Plc Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them
DE3271901D1 (en) * 1982-02-03 1986-08-07 Ici Plc Heterocyclic compounds useful as pesticides and processes for making them
US4505919A (en) * 1982-10-09 1985-03-19 Pfizer Inc. Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols
AU572889B2 (en) * 1983-09-26 1988-05-19 Sumitomo Chemical Company, Limited 1,2,4 - triazolyl propanols
KR930004193B1 (ko) * 1984-10-02 1993-05-21 스미또모 세이야꾸 가부시끼가이샤 N-치환된 트리아졸 유도체의 제조방법
US5081138A (en) * 1986-12-17 1992-01-14 Merck Frosst Canada, Inc. 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith
IT1198240B (it) * 1986-12-23 1988-12-21 Agrimont Spa Azolilderivati fungicidi
IT1232943B (it) * 1987-11-09 1992-03-10 Mini Ricerca Scient Tecnolog Azolilderivati fungicidi.
US5134152A (en) * 1989-12-07 1992-07-28 Sankyo Company, Limited Oxetane derivatives and their use as anti-fungal or fungicidal agents
CA2031892C (en) * 1989-12-25 2000-08-01 Minoru Tokizawa Triazole derivatives
CA2049802A1 (en) * 1990-08-26 1992-02-27 Sadao Oida Anti-fungal triazole derivatives, their preparation and uses
GB9307924D0 (en) * 1993-04-16 1993-06-02 Zeneca Ltd Chrial synthesis
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof
IT1273509B (it) * 1995-04-07 1997-07-08 Zambon Spa Composti azolici ad attivita' antimicotica per uso umano e veterinario

Also Published As

Publication number Publication date
OA10847A (en) 2003-02-05
AU713049B2 (en) 1999-11-25
HUP9900569A1 (hu) 1999-06-28
EP0877739B1 (en) 2002-06-12
ES2176689T3 (es) 2002-12-01
SK116198A3 (en) 1999-02-11
IL125701A (en) 2003-11-23
HUP9900569A3 (en) 2001-07-30
EA199800693A1 (ru) 1999-06-24
DE69713276D1 (de) 2002-07-18
CZ274898A3 (cs) 1999-01-13
UA55405C2 (uk) 2003-04-15
EE9800261A (et) 1999-02-15
CN1082050C (zh) 2002-04-03
DK0877739T3 (da) 2002-10-07
NO983953D0 (no) 1998-08-27
PT877739E (pt) 2002-11-29
KR19990087363A (ko) 1999-12-27
EE03684B1 (et) 2002-04-15
ATE219066T1 (de) 2002-06-15
AU2092997A (en) 1997-09-16
EP0877739A1 (en) 1998-11-18
NZ331919A (en) 1999-04-29
DE69713276T2 (de) 2003-03-06
EA003189B1 (ru) 2003-02-27
ZA971665B (en) 1997-08-29
IL125701A0 (en) 1999-04-11
US5869512A (en) 1999-02-09
PL328582A1 (en) 1999-02-01
WO1997031903A1 (en) 1997-09-04
ITMI960371A1 (it) 1997-08-28
JP2000505466A (ja) 2000-05-09
CN1212685A (zh) 1999-03-31
CZ291790B6 (cs) 2003-05-14
ITMI960371A0 (zh) 1996-02-28
BR9707773A (pt) 2000-01-04
IT1283038B1 (it) 1998-04-07
SI0877739T1 (en) 2002-12-31
BG102711A (bg) 1999-04-30
GEP20002091B (en) 2000-05-10
US6103909A (en) 2000-08-15
AP9801328A0 (en) 1998-09-30
NO983953L (no) 1998-10-26
TR199801688T2 (xx) 1998-11-23
CA2247390A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
HU189143B (en) Process for preparing 2-/2,4-difluoro-phenyl/-1,3-bis/1h-1,2,4-triazol-1-yl/-propan-2-ol derivatives
GB2099818A (en) Triazoles
US4661507A (en) Antifungal S-ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols and corresponding sulfoxides and sulfones
US4505919A (en) Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols
FI82038B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara triazolfoereningar.
US4483863A (en) Triazole antifungal agents
HU195647B (en) Fungicide composition containing triazol derivatives and process for producing the active agents
EP0115400B1 (en) Triazole antifungal agents
US4678789A (en) Triazole antifungal agents
FI75812B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara triazolderivat.
SK283391B6 (sk) Azolové zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
US4585778A (en) Triazole antifungal agents
FI83777B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-aryl-1-(fluorhydroxialkyl eller perfluoralkanoyl)-2-(1h-1,2,4-triazol-1-yl) etanoler.
AP875A (en) Azole compounds with antimycotic activity for human and veterinary use.
IE910456A1 (en) Aniline derivatives of Ó-styryl carbinols as antifungal¹agents
US20050261330A1 (en) Derivatives of 2,2,4-trisubstituted tetrahydrofuran an antifungal agents